10 analysts have shared their evaluations of Axsome Therapeutics (NASDAQ:AXSM) during the recent three months, expressing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 6 | 0 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 0 | 0 | 0 | 0 |
| 2M Ago | 0 | 3 | 0 | 0 | 0 |
| 3M Ago | 3 | 3 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Axsome Therapeutics, presenting an average target of $131.9, a high estimate of $180.00, and a low estimate of $107.00. This upward trend is evident, with the current average reflecting a 0.77% increase from the previous average price target of $130.89.
Analyzing Analyst Ratings: A Detailed...
Login or create a forever free account to read this news
Sign up/Log in
